Lindbrook Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-345
| Closed | -$32K | – | 2668 |
|
|
2021
Q4 | $32K | Hold |
345
| – | – | ﹤0.01% | 875 |
|
|
2021
Q3 | $21K | Hold |
345
| – | – | 0.01% | 736 |
|
|
2021
Q2 | $24K | Hold |
345
| – | – | 0.01% | 725 |
|
|
2021
Q1 | $24K | Hold |
345
| – | – | 0.01% | 694 |
|
|
2020
Q4 | $27K | Hold |
345
| – | – | 0.01% | 595 |
|
|
2020
Q3 | $26K | Hold |
345
| – | – | 0.01% | 538 |
|
|
2020
Q2 | $22K | Hold |
345
| – | – | 0.01% | 580 |
|
|
2020
Q1 | $14K | Hold |
345
| – | – | 0.01% | 672 |
|
|
2019
Q4 | $16K | Hold |
345
| – | – | 0.01% | 805 |
|
|
2019
Q3 | $16K | Hold |
345
| – | – | 0.01% | 782 |
|
|
2019
Q2 | $20K | Hold |
345
| – | – | 0.01% | 715 |
|
|
2019
Q1 | $15K | Hold |
345
| – | – | 0.01% | 795 |
|
|
2018
Q4 | $13K | Buy |
+345
| New | +$13.5K | 0.01% | 762 |
|
Lindbrook Capital's ARNA Position: Q1 2022 in Review
Lindbrook Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 345 shares — an estimated $32K sold.
Lindbrook Capital first reported a position in ARNA in Q4 2018 and held it in 13 quarters. The position peaked at $32K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Lindbrook Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Lindbrook Capital sold 345 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $32K.
- Lindbrook Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 13 quarters.
- Lindbrook Capital's Arena Pharmaceuticals Inc position peaked at $32K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Lindbrook Capital's 13F filing for Q1 2022, filed 21 Apr 2022.